Inhibrx Biosciences, Inc.
INBX
$111.69
-$1.17-1.04%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -17.51% | 30.14% | -18.86% | -17.94% | -13.83% |
| Total Receivables | -29.03% | 5.08% | -78.85% | -13.44% | 351.87% |
| Inventory | -21.92% | -17.23% | -16.52% | -9.19% | 31.29% |
| Prepaid Expenses | -6.20% | 25.55% | 41.20% | 45.06% | -8.35% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -1.88% | 6.88% | -9.09% | 12.85% | -28.20% |
| Total Current Assets | -17.00% | 28.99% | -17.71% | -16.78% | -13.17% |
|
|
|||||
| Total Current Assets | -17.00% | 28.99% | -17.71% | -16.78% | -13.17% |
| Net Property, Plant & Equipment | -12.21% | -11.01% | -10.11% | -9.12% | -8.88% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.93% | 0.00% | -23.70% | -15.73% | 0.09% |
| Total Assets | -16.17% | 25.59% | -17.46% | -16.33% | -12.58% |
|
|
|||||
| Total Accounts Payable | 8.81% | -5.08% | -9.45% | -24.20% | -4.79% |
| Total Accrued Expenses | 3.85% | -33.95% | -5.05% | 5.07% | -16.83% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.45% | 3.53% | 3.52% | 3.60% | 9.93% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 5.85% | -21.56% | -6.07% | -7.59% | -10.77% |
|
|
|||||
| Total Current Liabilities | 5.85% | -21.56% | -6.07% | -7.59% | -10.77% |
| Long-Term Debt | 0.74% | 74.02% | 0.64% | 0.64% | 0.63% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -18.48% | -15.29% | -12.95% | -11.23% | -9.54% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.07% | 48.03% | -1.53% | -2.03% | -3.13% |
|
|
|||||
| Common Stock & APIC | 1.82% | 1.74% | 1.60% | 1.43% | 1.14% |
| Retained Earnings | -13.11% | -13.58% | -15.39% | -19.80% | -19.17% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -151.85% | -363.17% | -78.30% | -46.28% | -27.41% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -151.85% | -363.17% | -78.30% | -46.28% | -27.41% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -151.85% | -363.17% | -78.30% | -46.28% | -27.41% |
|
|
|||||